PubRank

Peter Balfe

Author PubWeight™ 52.87‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. Gastroenterology 2006 3.44
2 Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies. Hepatology 2008 3.09
3 Hepatitis C virus infects the endothelial cells of the blood-brain barrier. Gastroenterology 2011 2.51
4 Blinded, multicenter comparison of methods to detect a drug-resistant mutant of human immunodeficiency virus type 1 at low frequency. J Clin Microbiol 2006 2.45
5 Hepatitis C virus receptor expression in normal and diseased liver tissue. Hepatology 2008 2.43
6 Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmission. AIDS 2006 2.23
7 Diverse CD81 proteins support hepatitis C virus infection. J Virol 2006 2.07
8 Molecular characterization of human immunodeficiency virus type 1 and hepatitis C virus in paid blood donors and injection drug users in china. J Virol 2004 1.76
9 Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity. J Virol 2007 1.68
10 Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission. J Virol 2010 1.67
11 Claudin association with CD81 defines hepatitis C virus entry. J Biol Chem 2010 1.67
12 Inferring viral quasispecies spectra from 454 pyrosequencing reads. BMC Bioinformatics 2011 1.62
13 CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry. J Virol 2008 1.62
14 Development of the antibody response in acute HIV-1 infection. AIDS 2004 1.54
15 Identification of a residue in hepatitis C virus E2 glycoprotein that determines scavenger receptor BI and CD81 receptor dependency and sensitivity to neutralizing antibodies. J Virol 2008 1.48
16 Paracrine signals from liver sinusoidal endothelium regulate hepatitis C virus replication. Hepatology 2013 1.47
17 Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells. J Virol 2009 1.44
18 Effect of cell polarization on hepatitis C virus entry. J Virol 2007 1.41
19 Hepatitis C virus infection of neuroepithelioma cell lines. Gastroenterology 2010 1.35
20 Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies. Vaccine 2007 1.28
21 Hepatitis C virus infection reduces hepatocellular polarity in a vascular endothelial growth factor-dependent manner. Gastroenterology 2009 1.17
22 Hepatitis C virus induces CD81 and claudin-1 endocytosis. J Virol 2012 1.14
23 Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity. J Virol 2009 1.13
24 Protein kinase A-dependent step(s) in hepatitis C virus entry and infectivity. J Virol 2008 1.12
25 Hepatitis C virus association with peripheral blood B lymphocytes potentiates viral infection of liver-derived hepatoma cells. Blood 2008 1.05
26 Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failure. J Virol 2002 1.05
27 A CCR5-tropic simian-HIV molecular clone capable of inducing AIDS in rhesus macaques. J Acquir Immune Defic Syndr 2005 1.05
28 Hepatoma cell density promotes claudin-1 and scavenger receptor BI expression and hepatitis C virus internalization. J Virol 2009 1.04
29 Hepatitis C virus entry and neutralization. Clin Liver Dis 2008 1.02
30 A dual role for hypoxia inducible factor-1α in the hepatitis C virus lifecycle and hepatoma migration. J Hepatol 2011 1.00
31 Early infection events highlight the limited transmissibility of hepatitis C virus in vitro. J Hepatol 2013 0.90
32 Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses. J Virol 2014 0.90
33 In silico directed mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface. Cell Microbiol 2012 0.85
34 Structural characterization of CD81-Claudin-1 hepatitis C virus receptor complexes. Biochem Soc Trans 2011 0.77
35 Disease progression in heterosexual patients infected with closely related subtype B strains of HIV type 1 with differing coreceptor usage properties. AIDS Res Hum Retroviruses 2004 0.76